Idera Pharmaceuticals Net Tangible Assets

Idera Pharmaceuticals (IDRA) currently reports a net tangible assets of $23M as of March 2023. That compares with $26M in the prior-year period — down 12.8% year over year. Use the charts on this page to explore Idera Pharmaceuticals's net tangible assets history and peer comparisons.

Idera Pharmaceuticals's net tangible assets decreased from $26M to $23M — a 12.8% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Idera Pharmaceuticals reported $23M in net tangible assets as of March 2023. That compares with $26M in the prior-year period — down 12.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Idera Pharmaceuticals, and consider following IDRA for alerts when major investors trade the stock.

Idera Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDRA with unrelated industries.